Fosun Pharma buys back shares on Shanghai Stock Exchange

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKEX: 2196) announced today it has repurchased 1,023,200 of its own ordinary shares on the Shanghai Stock Exchange. The shares were repurchased at prices ranging from RMB 23.41 to RMB 23.69 per share. The total consideration paid for the buyback amounted to RMB 24,067,542. Following the repurchase, the company's issued share capital stands at 2,119,385,965 shares, which includes 8,314,200 treasury shares. The repurchase was authorized under a previously granted mandate, and the company has placed a moratorium on issuing new shares or selling treasury shares for a period of up to 30 days after the repurchase.